Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of today's most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.
| Website | http://www.cambrianbio.com |
| Revenue | $5 million |
| Employees | 29 (19 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+18 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Drug Development, Biotechnology, Therapeutics, Drug Discovery, Clinical Stage, Pharmaceutical, Disease Prevention, Biopharmaceutical, Clinical Trials, Pharmaceutical Research, Healthspan, Biomedical, Modern Healthcare, Life Sciences, New Drugs, Healthcare Innovation, Scientific Research |
| Competitors | Amgen, Novozymes, Codexis, Inc., Pivot Bio, LanzaTech, Seres Therapeutics, Geno, Zymergen, Inc., Arzeda, Telesis Bio +45 more (view full list) |
Looking for a particular Cambrian Bio employee's phone or email?
Cambrian Bio Questions
The Cambrian Bio annual revenue was $5 million in 2026.
James Peyer is the Founder and CEO of Cambrian Bio.
19 people are employed at Cambrian Bio.
Cambrian Bio is based in New York, New York.
Top Cambrian Bio Employees
-
James Peyer
Founder and CEO at Cambrian Bio
New York, NY, US33 -
Erik Schneider
VP, Business Development and Strategy at Cambrian Bio
New York, NY, US32 -
Mark Nuttall
Chief Business Officer at Cambrian Bio
Cambridge, MA, US25 -
22
-
21
-
Margaret Kurtz
Senior Director of People and Culture at Cambrian Bio
New York, NY, US25+ -
Wenjie Luo
Director, Business Operations at Cambrian Bio
New York, NY, US21 -
24
-
25
-
Mary Phelan
Controller at Cambrian Bio
New York, United States14
Related Companies
